Annual report pursuant to Section 13 and 15(d)

Condensed Consolidated Statements of Cash Flows

v3.23.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:      
Net earnings, including noncontrolling interest $ 285,442 $ 263,099 $ 139,585
Adjustments to reconcile net earnings to net cash provided by operating activities:      
Depreciation and amortization 107,238 101,069 87,747
Costs recognized on sale of acquired inventory 400 1,596 1,565
Deferred income taxes (29,567) 6,816 (27,431)
Stock-based compensation expense 39,230 42,183 48,982
Fair value adjustment to contingent consideration payable (12,100) (20,400) 5,300
Contingent consideration payments - operating   (3,300) (337)
(Gain) Loss on investment, net (37,176)    
Fair value adjustment on available-for-sale investments (472) (15,002) 67,879
(Gain) loss on equity method investment 1,143    
Asset impairment restructuring   546  
Eminence impairment   18,715  
Gain on sale of Eminence (11,682)    
Leases, net 2,059 (1,201) 75
Other operating activity 455 668 (464)
Change in operating assets and operating liabilities, net of acquisition:      
Trade accounts and other receivables, net (20,867) (57,596) (15,549)
Inventories (30,167) (32,007) (7,140)
Prepaid expenses (4,585) (3,082) (1,101)
Trade accounts payable, accrued expenses, contract liabilities, and other (7,908) 12,741 19,091
Salaries, wages and related accruals (24,558) 7,760 20,536
Income taxes payable (2,492) 2,667 13,426
Net cash provided by (used in) operating activities 254,393 325,272 352,164
CASH FLOWS FROM INVESTING ACTIVITIES:      
Proceeds from maturities of available-for-sale investments 35,236 26,055 66,377
Purchases of available-for-sale investments (20,500) (52,998) (39,684)
Proceeds from sale of CCXI investment 73,219    
Additions to property and equipment (38,244) (44,908) (44,301)
Acquisitions, net of cash acquired (101,184)   (225,352)
Investment in unconsolidated entity, net     (556)
Proceeds from sale of Eminence 17,824    
Investment of forward purchase contract   (25,000)  
Investment in Wilson Wolf (232,000)    
Net cash provided by (used in) investing activities (265,649) (96,851) (243,516)
CASH FLOWS FROM FINANCING ACTIVITIES:      
Cash dividends (50,285) (50,185) (49,622)
Proceeds from stock option exercises 29,813 77,155 65,092
Re-purchases of common stock (19,562) (160,950) (43,178)
Borrowings under line-of-credit agreement 619,661 90,000 256,000
Repayments of long-term debt (525,661) (175,500) (271,500)
Contingent consideration payments - financing   (700)  
Taxes paid on RSUs and net share settlements (28,893) (23,461) (19,343)
Other financing activity (2,457) 788  
Net cash provided by (used in) financing activities 22,616 (242,853) (62,551)
Effect of exchange rate changes on cash and cash equivalents (3,356) (12,092) 6,369
Net change in cash and cash equivalents 8,004 (26,524) 52,466
Cash and cash equivalents at beginning of period 172,567 199,091 146,625
Cash and cash equivalents at end of period $ 180,571 $ 172,567 $ 199,091